Nutr Res Pract.  2008 Dec;2(4):218-226. 10.4162/nrp.2008.2.4.218.

Effects of soybean isoflavone extract on the plasma lipid profiles and antioxidant enzyme activity in streptozotocin-induced diabetic rats

Affiliations
  • 1Department of Food Science and Nutrition, Kyungpook National University, 1370 Sankyuk-dong, Puk-ku, Daegu 702-701, Korea. hslee@knu.ac.kr

Abstract

The present study evaluated the effects of various dosages of soybean isoflavone extract on lipid profiles, lipid peroxidation and antioxidant activities in streptozotocin-induced diabetic rats. The one normal control group was fed an AIN-76-based experimental diet and four diabetic groups were fed the same diet, supplemented with four different levels of soybean isoflavone extract for seven weeks. The daily dosages of pure isoflavone for four diabetic groups were set to be 0 mg (diabetic control), 0.5 mg (ISO-I), 3.0 mg (ISO-II) and 30.0 mg (ISO-III) per kilogram of body weight, respectively. The plasma total cholesterol levels and the TBA-reactive substances contents in the liver and kidney were significantly lowered in ISO-II and ISO-III groups compared to those in the diabetic control group. The levels of plasma HDL-cholesterol, plasma vitamin A and hepatic superoxide dismutase were significantly increased in those two groups compared with the diabetic control group. The present study demonstrated the possibility that the diets supplemented with 3.0 mg and 30.0 mg of soybean isoflavone extract may have beneficial effects on the plasma lipids, tissue lipid peroxidation and partly on antioxidant system in diabetic animals and there were no significant differences between the ISO-II and ISO-III groups. The results suggest that the effective daily dosage level of isoflavone for improving lipid metabolism in diabetic rats may be above 3.0 mg per kilogram body weight.

Keyword

Soybean isoflavone extract; diabetic rat; lipid profiles; antioxidant

MeSH Terms

Animals
Body Weight
Cholesterol
Diet
Kidney
Lipid Metabolism
Lipid Peroxidation
Liver
Plasma
Rats
Soybeans
Superoxide Dismutase
Vitamin A
Cholesterol
Superoxide Dismutase
Vitamin A

Reference

1. Abei H. Catalase in the Method of Enzymatic Analysis. 1974. Vol. 2. New York. USA: Academic Press;p. 673–684.
2. Alekel DL, Germain A, Peterson CT, Hanson HB, Stewart JW, Toda T. Isoflavone-rich soy protein attenuates bone loss in the lumber spine of premenopausal women. Am J Clin Nutr. 2000; 72:844–852. PMID: 10966908.
3. Ali AA, Velasquez MT, Hansen CT, Mohamed AI, Bhathena SJ. Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J Nutr Biochem. 2005; 16:693–699. PMID: 16081264.
Article
4. Allain CC, Poon LS, Chen CS, Richmond W. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20:470–475. PMID: 4818200.
Article
5. Alper G, Olukman M, İrer S, Cağlayan O, Duman E, Yılmaz C, Ülker S. Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat. Diabetes Metab Res Rev. 2006; 22:190–197. PMID: 16216038.
Article
6. Al-Shamaony L, Al-Khazraji SM, Twailiv IA. Hyperglycemic effect of Artemisia herba alba. II. Effect of a valuable extact on some blood parameters in diabetic animals. J Ethnopharmacol. 1994; 43:167–171. PMID: 7990489.
7. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Hearth Nutr. 1998; 2:489–504.
Article
8. Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr. 1999; 70:464S–474S. PMID: 10479219.
Article
9. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996; 126:43–50. PMID: 8558324.
Article
10. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr. 1996; 126:161–167. PMID: 8558297.
Article
11. Bieri G, Toliver JJ, Catignani GL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red blood cells by high pressure liquid chromatography. Am J Clin Nutr. 1979; 32:2143–2149. PMID: 484533.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248–254. PMID: 942051.
Article
13. Bucolo G, David H. Quantitative determination of serum triglycerides by use of exzymes. Clin Chem. 1973; 19:476–482. PMID: 4703655.
14. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocirnol Metab. 1999; 84:3479–3484.
Article
15. Eldridge AC, Kwolek WF. Soybean isoflavones: Effect of environment and variety on composition. J Agric Food Chem. 1983; 31:394–396. PMID: 6682871.
Article
16. Exner M, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Held I, Gmeiner BM. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein. Free Radic Res. 2001; 34:101–112. PMID: 11234992.
Article
17. Finley PR, Schifman RB, Williams RJ, Luchti DA. Cholesterol in high-density lipoprotein : Use of mg2+/dextran sulfate in its measurement. Clin Chem. 1978; 24:931–933. PMID: 207463.
18. Folch JM, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissue. J Bio Chem. 1957; 226:497–509. PMID: 13428781.
19. Gallaher DD, Csallany AS, Shoeman DW, Olson JM. Diabetes increases excretion of urinary malonaldehyde conjugates in rats. Lipids. 1993; 28:663–666. PMID: 8355596.
Article
20. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller MM. Enhanced serum level of thiobarbituricacid-reactive substances in diabetic mellitus. Am J Med. 1995; 98:469–475. PMID: 7733126.
21. Hsu CS, Chiu WC, Yeh SH. Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr Res. 2003; 23:67–75.
Article
22. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002; 25:1709–1714. PMID: 12351466.
Article
23. Jenkins DJ, Kendall CW, Jacson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002; 76:365–372. PMID: 12145008.
Article
24. Kaleem M, Asif M, Ahmed QU, Bano B. Antidiatic and antioxidant activity of Annona squamosa extract in streptozotoc-ininduced diabetic rats. Singapore Med J. 2006; 47:670–675. PMID: 16865205.
25. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J. 1996; 320:855–863. PMID: 9003372.
Article
26. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract. 2001; 53:33–39. PMID: 11378211.
Article
27. Kim JS, Kwon CS. Estimated dietary isoflavone intake of Korean population based on National Nutrition Survey. Nutr Res. 2001; 21:947–953. PMID: 11446978.
Article
28. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones erduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr. 1998; 128:954–959. PMID: 9614153.
29. Kudou S, Fluery Y, Welti D, Magnolato D, Uchida T, Kitamura K, Okaubo K. Malonyl isoflavone glycosides in soybean seeds (Glycine max Merrill). Agric Biol Chem. 1991; 55:2227–2233.
30. Kuiper JM, Carrison B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997; 139:4252–4257. PMID: 9751507.
31. Lee HS, Choi MS, Lee YK, Park SH, Kim YJ. Astudy on the development of high-fiber supplements for the diabetic patients-Effect of seaweed supplementation on the lipid and glucose metabolism in streptozotocin-induced diabetic rats. The Korean Journal of Nutrition. 1996; 29:296–306.
32. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities and lipid profile in streptozitocin-induced diabetic rats. Life Sci. 2006; 79:1578–1584. PMID: 16831449.
33. Lee KA. Effects of isoflavone-rich bean sprout on the metabolism of diabetic rats. 2002. Kyungpook National University of Korea;MS thesis.
34. Lee SK, Lee MJ, Yoon S, Kwon DJ. Estimated isoflavone intake from soy products in Korean middle-aged women. Journal of the Korean Society of Food Science and Nutrition. 2000; 29:948–956.
35. Liu D, Zhen W, Yang Z, Carter JD, Si H, Reynolds KA. Genistein acutely stimulates insulin secretion in pancreatic β-cells through a Camp-dependent protein kinase pathway. Diabetes. 2006; 55:1043–1050. PMID: 16567527.
Article
36. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a covenient assay for superoxide dismutase. Eur J Bio Chem. 1974; 47:469–474.
37. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res. 1989; 30:1827–1834. PMID: 2621411.
Article
38. Naaz A, Yellayi S, Zakroczymski MA. The soy isoflavone genistein decreaseds adipose deposition in mice. Endocrinology. 2003; 144:3315–3320. PMID: 12865308.
39. Nelson GJ, Morris VC, Schmidt PC, Levander O. The urinary excretion of thiobarbituric acid reactive substances and malondialdehyde by normal adult males after consuming a diet containing solmon. Lipids. 1993; 28:757–761. PMID: 8377591.
40. Ohta n, Kuwata G, Akahori H, Watanabe T. Isolation of a new isoflavone acely glucoside, 6"-O-acetylgenistin, from soybeans. Agric Biol Chem. 1980; 44:469–470.
41. Packer L. The role of anti-oxidative treatment in diabetes mellitus. Diabetologia. 1993; 36:1212–1213. PMID: 8270140.
Article
42. Paglia PE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70:158–169. PMID: 6066618.
43. Palmeira CM, Santos DL, Seica R, Moreno AJ, Santos MS. Enhanced mitochondrial testicular antioxidant capacity in Goto-Kakizaki diabetic rats: role of coenzyme Q. Am J Physiol Cell Physiol. 2001; 281:C1023–C1028. PMID: 11502580.
Article
44. Park SH, Lee HS. Effects of legume supplementation on the glucose and lipid metabolism and lipid peroxidation in streptosotoc-ininduced diabetic rats. The Korean Journal of Nutrition. 2003; 36:425–436.
45. Pratt D, Pietro CD, Porter W, Giffee JW. Phenolic antioxidants of soy protein hydrolyzates. J Food Sci. 1981; 47:24–27.
Article
46. Raines EW, Ross R. Biology of atherosclerotic plaque formation possible role of growth factors in lesion development and the potential impact of soy. J Nutr. 1995; 125:624S–630S. PMID: 7884544.
47. Ravi K, Ramachandran B, Subramanian S. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats. Life Sci. 2004; 75:2717–2731. PMID: 15369706.
Article
48. Sale FD, Marchesini S, Fishman PH, Berra B. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. 1984. New York. USA: Academic Press Inc.;p. 347–350.
49. Setchell KDR, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr. 1999; 129:758S–767S. PMID: 10082786.
Article
50. Seven A, Güzel S, Scymen O, Civelek S, Bolayırl M, Uncu M, Gurçak B. Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: Investigation of liver and plasma. Yonsei Med J. 2004; 45:703–710. PMID: 15344213.
Article
51. Shim JY, Kim KO, Seo BH, Lee HS. Soybean isoflavone extract improves glucose tolerance and raises the survival rate in streptozotocin-induced diabetic rats. Nutrition Research and Practice. 2007; 1:266–272.
Article
52. Sidney PG, Bernald R. Improved menual Spectrometric procedure for determination of serum triglyceride. Clin Chem. 1973; 19:1077–1078. PMID: 4744812.
53. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obst Gynecol. 2001; 97:109–115. PMID: 11152918.
Article
54. Taladgis BG, Pearson AM, Duan LR. Chemistry of the 2-thiobarbituric acid test for determination of oxidation of oxidative rancidity in foods. J Sci Food Agric. 1964; 15:602–607.
55. Taskinen MR. Lipoprotein lipase in diabetes. Diabetes Metab Rev. 1987; 3:551–570. PMID: 3552532.
Article
56. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endo Metab. 2001; 86:3053–3060.
Article
57. The Korean Society of Food Science and Nutrition. Handbook of experiments in food science and nutrition. 2000. Seoul. Republic of Korea: Hyoil Publishing Co.;p. 480–483.
58. Tuitoek PJ, Ritter SJ, Smith JE, Basu TK. Streptozotoc-ininduced diabetes lowers trtinol-binding protein and transthyretin concentrations in rats. Br J Nutr. 1996; 76:891–897. PMID: 9014657.
59. Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savi H, Bayraktar N. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol. 2002; 39:17–122.
Article
60. Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissue by TBA test. Anal Biochem. 1978; 86:271–278. PMID: 655387.
61. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem. 1994; 42:1666–1673.
Article
62. Wei H, Cai Q, Rahn RO. Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis. 1996; 17:73–77. PMID: 8565140.
63. Wei H, Wei L, Frenkel K, Bowen R, Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer. 1993; 20:1–12. PMID: 8415125.
64. Zhang M, Xie X, Lee AH, Binns CW. Soy isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer. 2004; 49:125–130. PMID: 15489204.
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr